A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials

被引：0
|
作者：
Wright, Grace C. [1 ]
Mysler, Eduardo [2 ]
Yndestad, Arne [3 ]
Kinch, Cassandra D. [4 ]
Ogdie, Alexis [5 ]
机构：
[1] Assoc Women Rheumatol, New York, NY USA
[2] Org Med Invest, Div Rheumatol, Buenos Aires, Argentina
[3] Pfizer Inc, Inflammat & Immunol, Oslo, Norway
[4] Pfizer Canada ULC, Inflammat & Immunol, Kirkland, PQ, Canada
[5] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA USA
来源：
RHEUMATOLOGY AND THERAPY | 2025年
关键词：
Race; Ethnicity; Health disparities; Clinical trials; Outcomes;
D O I：
10.1007/s40744-025-00751-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Letter to the Editor Regarding the Article "Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials"
    Qiu, Yanran
    Sun, Jing
    RHEUMATOLOGY AND THERAPY, 2025,
  • [2] Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
    Wright, Grace C.
    Mysler, Eduardo
    Kwok, Kenneth
    Cadatal, Mary Jane
    Germino, Rebecca
    Yndestad, Arne
    Kinch, Cassandra D.
    Ogdie, Alexis
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1135 - 1164
  • [3] IMPACT OF RACE ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, 3 AND 3B/4 CLINICAL TRIALS
    Wright, G. C.
    Mysler, E.
    Chen, Y. H.
    Kinch, C.
    Yndestad, A.
    Kwok, K.
    Cadatal, M. J.
    Germino, R.
    Ogdie, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 609 - 609
  • [4] A Response to: Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance"
    Batko, Bogdan
    Rivas, Jose L.
    RHEUMATOLOGY AND THERAPY, 2025, 12 (02) : 403 - 405
  • [5] Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance"
    Goyal, Manjeet Kumar
    RHEUMATOLOGY AND THERAPY, 2025, 12 (02) : 401 - 402
  • [6] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    Tesser, John
    Gul, Ahmet
    Olech, Ewa
    Oelke, Kurt
    Lukic, Tatjana
    Kwok, Kenneth
    Ebrahim, Abbas
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [7] Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
    John Tesser
    Ahmet Gül
    Ewa Olech
    Kurt Oelke
    Tatjana Lukic
    Kenneth Kwok
    Abbas Ebrahim
    Arthritis Research & Therapy, 25
  • [8] A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”
    Andrew Menzies-Gow
    Flavia L. Hoyte
    David B. Price
    David Cohen
    Peter Barker
    James Kreindler
    Maria Jison
    Christopher L. Brooks
    Peggy Papeleu
    Rohit Katial
    Advances in Therapy, 2022, 39 : 3862 - 3865
  • [9] A Response to: Letter to the Editor Regarding "Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab"
    Menzies-Gow, Andrew
    Hoyte, Flavia L.
    Price, David B.
    Cohen, David
    Barker, Peter
    Kreindler, James
    Jison, Maria
    Brooks, Christopher L.
    Papeleu, Peggy
    Katial, Rohit
    ADVANCES IN THERAPY, 2022, 39 (08) : 3862 - 3865
  • [10] Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Yamaoka, Kunihiro
    Arai, Shoko
    Toyoizumi, Shigeyuki
    DeMasi, Ryan
    Fukuma, Yuri
    Hirose, Tomohiro
    Sugiyama, Naonobu
    Zwillich, Samuel H.
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 756 - 766
12345